Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis: A Dose-Ranging Study

OBJECTIVE: Metronidazole vaginal gel (MVG) 0.75% is a US Food and Drug Administration–approved, 5-day treatment for bacterial vaginosis (BV). This study tested the hypothesis that a shorter treatment course at a higher dose (MVG 1.3%) would yield similar efficacy to 5 days of MVG 0.75%. MATERIALS AN...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Low Genit Tract Dis
Main Authors: Chavoustie, Steven E., Jacobs, Mark, Reisman, Howard A., Waldbaum, Arthur S., Levy, Sharon F., Hillier, Sharon L., Nyirjesy, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2015
Assuntos:
Original Articles: Vulva and Vagina
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376277/
https://ncbi.nlm.nih.gov/pubmed/24983350
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/LGT.0000000000000062
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados